SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 13, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 6h ago
Insider cluster: 2 insiders, $796K total
Actionable Insight • Neutral

The insider sales are small and pre-planned, carrying no negative signal. Monitor next quarter for RASONQUE revenue trajectory and any insider buying that would indicate conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Revolution Medicines sold shares in the week following Q3 earnings that showed RASONQUE revenue far exceeding consensus. CFO Anders Jack sold $633K and Anthony Mancini sold $162K, both under 10b5-1 plans. The total open-market sales of ~$796K represent ~0.002% of the $39.1B market cap, a trivial amount that does not alter the positive earnings read-through.

Key Financial Metrics

Direction
selling
Total Value
$796.0K
Insiders
2

Key Facts

  • CFO Anders Jack sold 3,500 shares at $181.04 for $633K on 2026-11-11 under a 10b5-1 plan
  • Anthony Mancini sold 811 shares at $200.00 for $162K on 2026-11-09 under a 10b5-1 plan
  • Total open-market sales of ~$796K represent ~0.002% of the $39.1B market cap
  • Sales occurred 5-7 days after Q3 earnings showing RASONQUE revenue of $197.6M vs consensus $27.3M
  • Both sales were pre-planned under 10b5-1 trading plans, reducing informational content

Financial Impact

~$796K in open-market sales, immaterial relative to $39.1B market cap

insider ownership

Risk Factors

  • Insider sales are trivial in size and under 10b5-1 plans, so no material risk signal
  • No risk to current positive earnings narrative from this cluster

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (31 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RVMD-1794610841253

Track record

44 reports on RVMD

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Viewing Entry $176.02 Now $166.87 −5.20% settles Feb 12
  4. Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
  5. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
  6. Nov 4, 202612d ago 8-K Bullish 7/10 No price data
  7. Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
  8. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
  9. Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
  10. Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
Showing 10 of 44

US Market Status

Market Closed · Opens in 8h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026